The association between mutations of key driver genes and colorectal cancer (CRC)
metastasis has been investigated by many studies. However, the results of these studies …

Colorectal cancer (CRC) is a complex and molecularly heterogeneous disease representing
one of the most frequent causes of cancer-related death worldwide. About 8–15% of CRCs …

Around 8–12% of patients with advanced colon rectal cancer (CRC) present with BRAF
alterations, in particular V600E mutation, which is associated with right-side, poorly …

The pathologist emerged in the personalized medicine era as a central actor in the definition
of the most adequate diagnostic and therapeutic algorithms. In the last decade …

Colorectal cancers (CRCs) harboring the BRAF (V600E) mutation are associated with
aggressive disease and resistance to BRAF inhibitors by feedback activation of the receptor …

Background Mucinous differentiation occurs in 5–15 per cent of colorectal
adenocarcinomas. This subtype of colorectal cancer responds poorly to chemoradiotherapy …

Purpose To explore the potential of radiomics texture features as potential biomarkers to
enable detection of the presence of BRAF mutation and prediction of 5-year overall survival …

Advances in molecular biology have markedly increased our understanding of the
heterogeneous molecular landscape of colorectal cancer (CRC). Up to 15% of CRCs harbor …

Background Early detection of synchronous colorectal peritoneal metastases (CPMs) is
difficult due to the absence of typical symptoms and the low accuracy of imaging …

Abstract Background and Objectives Mucinous adenocarcinoma is a distinct subtype of
colorectal cancer (CRC) with a worse prognosis when compared with non‐mucinous …